08:03 AM EDT, 08/26/2025 (MT Newswires) -- Plus Therapeutics ( PSTV ) said Tuesday the Nasdaq confirmed that it has regained compliance with two of the stock exchange's listing rules.

Plus is now in compliance with the Market Value of Listing Securities standard, which requires certain companies to maintain a market value of listed securities of at least $35 million, and the alternative stockholders' equity threshold, which requires certain companies to maintain stockholders' equity of at least $2.5 million, the company said, citing a letter from Nasdaq.

Nasdaq has extended the deadline for the company to regain compliance with the $1.00 bid price rule to Nov. 12 from Sept. 8, due to its compliance with two criteria mentioned, Plus said.

Plus remains under Nasdaq's one-year panel monitoring period through Aug. 22, 2026, the company said.

The company's shares were up more than 7% in recent premarket activity on Tuesday.